4//SEC Filing
Sandercock Colin 4
Accession 0000950170-24-028613
CIK 0001645460other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:00 PM ET
Size
5.2 KB
Accession
0000950170-24-028613
Insider Transaction Report
Form 4
Sandercock Colin
SVP, GENERAL COUNSEL
Transactions
- Award
Stock Option (right to buy)
2024-03-06+175,000→ 175,000 totalExercise: $1.94Exp: 2034-03-05→ Common Stock (175,000 underlying)
Footnotes (1)
- [F1]This stock option becomes exercisable in eight equal semi-annual installments beginning on September 6, 2024.
Documents
Issuer
Cue Biopharma, Inc.
CIK 0001645460
Entity typeother
Related Parties
1- filerCIK 0001724870
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 4:00 PM ET
- Size
- 5.2 KB